Search
for
Sort by
Research 151–180 of 235
- Three-Dimensional Bioprinting: A Comprehensive Review for Applications in Tissue Engineering and Regenerative Medicine
- Flavonoids and saponins: What have we got or missed?
- Abstracts from the 4th Annual Student Medical Summit
- Characterization and Management of Hedgehog Pathway Inhibitor-Related Adverse Events in Patients With Advanced Basal Cell Carcinoma
- Aldo-Keto Reductase (AKR) 1C3 inhibitors: a patent review
- Optimizing treatment management of trastuzumab deruxtecan in clinical practice of breast cancer
- Coronavirus 2019 Infectious Disease Epidemic: Where We Are, What Can Be Done and Hope For
- Targeting Wnt Signaling for Gastrointestinal Cancer Therapy: Present and Evolving Views
- Simultaneous quantitation of nine hydroxy-androgens and their conjugates in human serum by stable isotope dilution liquid chromatography electrospray ionization tandem mass spectrometry
- Are sex hormones promising candidates to explain sex disparities in the COVID-19 pandemic?
- Merkel cell carcinoma: updates in tumor biology, emerging therapies, and preclinical models
- The Relationship Between Metformin and Serum Prostate‐Specific Antigen Levels
- Metformin and Malignant Tumors: Not Over the Hill
- Open-Label, Randomized, Multicenter, Phase III Study Comparing Oral Paclitaxel Plus Encequidar Versus Intravenous Paclitaxel in Patients With Metastatic Breast Cancer
- Tissue Resident Foxp3+ Regulatory T Cells: Sentinels and Saboteurs in Health and Disease
- Smoothened receptor inhibitor vismodegib for the treatment of basal cell carcinoma: a retrospective analysis of efficacy and side effects
- Clinical Guidance on the Monitoring and Management of Trastuzumab Deruxtecan (T-DXd)-Related Adverse Events: Insights from an Asia-Pacific Multidisciplinary Panel
- Logic-based modeling and drug repurposing for the prediction of novel therapeutic targets and combination regimens against E2F1-driven melanoma progression
- Barrett's esophagus as a premalignant condition; medical and surgical therapeutic management
- Perspective Chapter: Appraisal of Paclitaxel (Taxol) Pros and Cons in the Management of Cancer – Prospects in Drug Repurposing
- Cutaneous Sequelae After Burn Injury: Pruritus, Dyspigmentation and Malignancy—Mechanisms and Management
- Green Nanodrugs: Research Progress and Challenges of Plant-Derived Nanovesicles in Tumor Treatment
- Recent Progress and Morphological Distribution of Polydopamine-Based Biomaterials and Their Applications
- Research Advances in Therapeutic Strategies and Drug Delivery Systems for Pathological Scars
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- “From evidence to practice” – Insights from the multidisciplinary team on the optimal integration of GLP‐1 receptor agonists in obesity management services
- Cedrol restricts the growth of colorectal cancer <i>in vitro</i> and<i> in vivo</i> by inducing cell cycle arrest and caspase-dependent apoptotic cell death
- General adverse response to cyclophosphamide in Chinese patients with systemic autoimmune diseases in recent decade — a single-center retrospective study
- The role of WNT10B in physiology and disease: A 10-year update
- Increased Risk of Local Recurrence in Cutaneous Squamous Cell Carcinoma Arising in Sun-Exposed Skin: A Retrospective Cohort Study